Meeder Asset Management Inc Spero Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$7.27 - $14.18 $11,697 - $22,815	-1,609 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.27 - $10.41 $5,659 - $11,180	1,074 Added 200.75%	1,609 $13,000
Q3 2019 Oct 17, 2019	SELL	$9.01 - $12.55 $8,640 - $12,035	-959 Reduced 64.19%	535 $6,000
Q2 2019 Aug 05, 2019	BUY	$10.25 - $14.36 $12,146 - $17,016	1,185 Added 383.5%	1,494 $17,000
Q1 2019 Apr 16, 2019	BUY	$6.26 - $13.31 $1,934 - $4,112	309 New	309 $4,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.